GlassScriptPhysician profile
Amitabh Gulati
NPI 1285855486
$614,406.38
in general payments reported to CMS, 2019-2025
33 companies · $59K in 2025
The $59K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $26K · 2021: $107K · 2022: $167K · 2023: $129K · 2024: $114K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $189K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $43K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Grant: $442 · Gift: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $189,123.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,012.50 |
| Travel and Lodging | $43,401.90 |
| Food and Beverage | $14,947.28 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Grant | $441.63 |
| Gift | $271.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $335,109.45 | 2019-2025 | Sprint Pns System |
| Medtronic, INC. | $159,141.99 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Syncra Crt-P |
| Nalu Medical, INC. | $37,895.79 | 2021-2025 | Nalu Neurostimulation System |
| Hinge Health, INC. | $34,041.86 | 2022-2025 | Enso |
| Rivanna Medical, INC | $10,655.04 | 2022-2025 | Accuro, Accuro |
| Medtronic USA, INC. | $10,128.85 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,621.68 | 2019-2023 | Xifaxan |
| Pacira Pharmaceuticals Incorporated | $6,750.00 | 2022 | |
| Tersera Therapeutics LLC | $4,362.37 | 2022-2025 | Prialt |
| Stratus Medical, LLC | $2,445.81 | 2020-2023 | Nimbus |
| Grt US Holding, INC. | $1,897.62 | 2021-2022 | |
| Eisai INC. | $1,080.00 | 2022 | |
| Flowonix Medical Incorporated | $889.10 | 2019 | |
| Abbott Laboratories | $431.08 | 2019-2025 | Xience Skypoint, Cardiomems, Eterna |
| Biotronik Nro, INC. | $420.92 | 2024-2025 | Prospera |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $259.39 | 2022 | |
| Averitas Pharma INC. | $166.00 | 2024 | Qutenza |
| Bioness INC | $153.17 | 2020 | |
| Stimwave Technologies Incorporated | $143.04 | 2021-2022 | |
| Mml US, INC. | $128.87 | 2024 | Reactiv8 |
| Allergan, INC. | $90.61 | 2019-2021 | |
| Si-Bone, INC. | $88.68 | 2024-2025 | |
| Vertiflex, INC. | $81.63 | 2019 | |
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Boston Scientific Corporation | $70.24 | 2020 | |
| Heron Therapeutics, INC. | $69.07 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $52.70 | 2024 | |
| Foundation Fusion Solutions, LLC | $40.25 | 2021 | |
| Angiodynamics, INC. | $29.07 | 2025 | Alphavac |
| Janssen Pharmaceuticals, INC | $23.17 | 2024 | Xarelto |
| Saluda Medical Americas, INC. | $22.43 | 2023 | Evoke Scs |
| Takeda Pharmaceuticals U.S.A., INC. | $20.79 | 2024 | Entyvio |
| Nevro Corp. | $18.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amitabh Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.